3Behar S, Boyko E, Reicher RH, et al. Ten - year survival after acute myocardial infarction: comparison of patients with and without diabetes. Am Heart J 1997; 133: 290 ～ 6.
4Olsson J, Lindberg G and Gottsater M. Increased mortality in type .Ⅱ diabetic patients using sulphonylurea and metformin in combination:a population-based observational study. Diabetologia 2000;43(5) :558～60.
5Geiss LS, Herman WH, Smith PJ. Mortality in non-insulin-dependent diabetes. In: Harris MI, Cowie CC, Stern MP, et al, editors. Diabetes in Amerrica. 2nd ed. Washington, DC: US Gouvernment Printing Office 1995. p. 233～ 257.
6Charles M, Clark Jr and R. Clark Perry. Type 2 diabetes end macrovascular disease: epidemiology and etiology. Am Heart J 1999; 139: S330～ 333.
7Shaw KM. Macrovascular disease in diabetes. In: Shaw KM, editros. Diabetic complications. 1st ed. Copyright by Wiley J and Sons Ltd 1996. P. 182～ 184.
8Caballero AE, Arora S, Saouaf, et al. Macrovascular reaotivity is reduced in subjects at risk for type 2 diabetes. Diabetes1999;48:1856～ 1862.
9Frank B. HU, Meir JS, Caren S, et al. Diabetes mellitus and mortality formall - causes and coronary heart disease in women:20 years of follow- up. Diabetse 2000;49(Suppl 1) :A20.
